Cytochrome P-450 CYP2D6 Inhibitors
DBCAT000911Therapeutic category
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2D6. A DrugBank category of 268 drugs. 235 of them are approved.
- Also known as
- CYP2D6 Inhibitors · CYP2D6 Inhibitors, P450 · Cytochrome P 450 CYP2D6 Inhibitors · Cytochrome P-450 CYP2D6-Inhibitors · Cytochrome P450 2D6 Inhibitor
- Drugs
- (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE
- 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
- Abemaciclib
- Abiraterone
- Acebutolol
- Adagrasib
- Amiodarone
- Amitriptyline
- Amlodipine
- Amodiaquine
- Amoxapine
- Artenimol
- Asenapine
- Asunaprevir
- Atorvastatin
- Azelastine
- Belumosudil
- Bepridil
- Berberine
- Berotralstat
- Bicalutamide
- Biperiden
- Black cohosh
- Brincidofovir
- Buprenorphine
What you can answer from here — as of September 15, 2022
Which targets do Cytochrome P-450 CYP2D6 Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account